Immediate Impact

1 by Nobel laureates 3 from Science/Nature 65 standout
Sub-graph 1 of 22

Citing Papers

GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
2024 Standout
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
2 intermediate papers

Works of Ngai‐Moh Law being referenced

Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non‐alcoholic fatty liver disease
2019
Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non‐alcoholic fatty liver disease: A pilot randomized trial
2017

Author Peers

Author Last Decade Papers Cites
Ngai‐Moh Law 230 156 31 150 15 462
Sophie Marjoux 316 302 39 99 16 543
B Meyer-Wyss 249 184 84 113 19 537
E Lyrenäs 317 328 28 127 15 566
D N L Ralphs 303 163 45 101 28 569
In Kyung Sung 219 157 145 67 25 538
F L Iber 87 44 32 123 10 486
J Fakhry 179 66 50 89 20 456
Mitsue Okumura 278 126 34 148 13 480
C. Beglinger 312 216 96 54 19 550
Aziz Yazar 107 154 94 86 21 490

All Works

Loading papers...

Rankless by CCL
2026